Growth Metrics

Phibro Animal Health (PAHC) Cash from Investing Activities (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Cash from Investing Activities data on record, last reported at -$17.2 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 93.4% year-over-year to -$17.2 million; the TTM value through Dec 2025 reached -$63.5 million, up 76.61%, while the annual FY2025 figure was -$288.7 million, 499.01% down from the prior year.
  • Cash from Investing Activities reached -$17.2 million in Q4 2025 per PAHC's latest filing, up from -$21.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $17.6 million in Q4 2021 and bottomed at -$260.5 million in Q4 2024.
  • Average Cash from Investing Activities over 5 years is -$23.5 million, with a median of -$10.1 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: soared 330.43% in 2021, then plummeted 1715.13% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $17.6 million in 2021, then plummeted by 155.84% to -$9.8 million in 2022, then tumbled by 153.43% to -$24.9 million in 2023, then crashed by 947.72% to -$260.5 million in 2024, then skyrocketed by 93.4% to -$17.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$17.2 million in Q4 2025, -$21.0 million in Q3 2025, and -$7.0 million in Q2 2025.